SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-495883
Filing Date
2016-03-08
Accepted
2016-03-08 06:06:00
Documents
3
Period of Report
2016-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129165d8k.htm 8-K 18141
2 EX-99.1 d129165dex991.htm EX-99.1 11804
3 GRAPHIC g129165ex99_1logo.jpg GRAPHIC 5388
  Complete submission text file 0001193125-16-495883.txt   38753
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 161490244
SIC: 2834 Pharmaceutical Preparations